Mrv1909 03262102402D 30 34 0 0 1 0 999 V2000 -4.1987 0.5478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.3741 0.5478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9618 1.2622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8560 1.2271 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.6014 2.1911 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.7953 2.0081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4350 1.2612 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.7953 0.5191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6014 0.3361 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -2.2471 0.8488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2471 1.6736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3895 1.2612 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.8019 0.5468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3895 -0.1677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4350 -0.1677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8521 -0.8821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4350 -1.5964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3895 -1.5964 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.8019 -0.8821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6265 -0.8821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0389 -0.1677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6265 0.5468 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.8636 -0.1677 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.2806 -0.8821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.9407 -1.6358 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.5552 -2.1911 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 4.2696 -1.7789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1002 -0.9697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.0235 -2.1139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0235 0.5478 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 5 4 1 1 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 7 8 1 0 0 0 0 8 9 1 0 0 0 0 9 10 1 0 0 0 0 10 11 1 0 0 0 0 5 11 1 0 0 0 0 9 4 1 1 0 0 0 7 12 1 1 0 0 0 12 13 1 0 0 0 0 14 13 2 0 0 0 0 15 14 1 0 0 0 0 16 15 2 0 0 0 0 17 16 1 0 0 0 0 18 17 2 0 0 0 0 18 19 1 0 0 0 0 20 19 2 0 0 0 0 21 20 1 0 0 0 0 22 21 2 0 0 0 0 13 22 1 0 0 0 0 21 23 1 0 0 0 0 23 24 1 0 0 0 0 25 24 2 0 0 0 0 26 25 1 0 0 0 0 26 27 1 0 0 0 0 28 27 2 0 0 0 0 24 28 1 0 0 0 0 27 29 1 0 0 0 0 14 19 1 0 0 0 0 1 30 3 0 0 0 0 M END > DB16660 > drugbank > CC1=CC(NC2=NC(N[C@H]3C[C@@H]4CC[C@H](C3)N4CCC#N)=C3C=CC=NC3=C2)=NN1 > InChI=1S/C22H26N8/c1-14-10-21(29-28-14)26-20-13-19-18(4-2-8-24-19)22(27-20)25-15-11-16-5-6-17(12-15)30(16)9-3-7-23/h2,4,8,10,13,15-17H,3,5-6,9,11-12H2,1H3,(H3,25,26,27,28,29)/t15-,16-,17+ > DADAEARVGOQWHV-OSYLJGHBSA-N > C22H26N8 > 402.506 > 402.228042869 > 7 > 56 > 0.6688945458304791 > 44.79227513070789 > 1 > 3 > 0 > 1 > 3-[(1R,3S,5S)-3-({7-[(5-methyl-1H-pyrazol-3-yl)amino]-1,6-naphthyridin-5-yl}amino)-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile > 3.87 > 2.438132497 > -3.82 > 1 > 1 > 5 > 1 > 17.491111179236764 > 13.246390789215404 > 7.298469939446914 > 105.54999999999998 > 118.37580000000004 > 6 > 1 > 6.10e-02 g/l > 3-[(1R,3R,5S)-3-({7-[(5-methyl-1H-pyrazol-3-yl)amino]-1,6-naphthyridin-5-yl}amino)-8-azabicyclo[3.2.1]octan-8-yl]propanenitrile > 0 > DB16660 > investigational > Izencitinib > 3-((1r,3s,5s)-3-((7-((5-methyl-1h-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo(3.2.1)octan-8-yl)propanenitrile; 8-azabicyclo(3.2.1)octane-8-propanenitrile, 3-((7-((5-methyl-1h-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-, (3-exo)- $$$$